Patents by Inventor Peter Bakhit

Peter Bakhit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS CONTAINING ALPHA-2-ADRENERGIC AGONIST COMPONENTS
    Publication number: 20200069576
    Abstract: Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
    Type: Application
    Filed: April 4, 2019
    Publication date: March 5, 2020
    Inventors: Richard Graham, Peter Bakhit, Orest Olejnik
  • Compositions containing alpha-2-adrenergic agonist components
    Patent number: 10307368
    Abstract: Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: June 4, 2019
    Assignee: ALLERGAN, INC.
    Inventors: Richard Graham, Peter Bakhit, Orest Olejnik
  • COMPOSITIONS CONTAINING ALPHA-2-ADRENERGIC AGONIST COMPONENTS
    Publication number: 20180021254
    Abstract: Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
    Type: Application
    Filed: April 6, 2017
    Publication date: January 25, 2018
    Inventors: Richard Graham, Peter Bakhit, Orest Olejnik
  • Compositions containing alpha-2-adrenergic agonist components
    Patent number: 9687443
    Abstract: Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
    Type: Grant
    Filed: February 19, 2016
    Date of Patent: June 27, 2017
    Assignee: ALLERGAN, INC.
    Inventors: Richard Graham, Peter Bakhit, Orest Olejnik
  • COMPOSITIONS CONTAINING ALPHA-2-ADRENERGIC AGONIST COMPONENTS
    Publication number: 20160310416
    Abstract: Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
    Type: Application
    Filed: February 19, 2016
    Publication date: October 27, 2016
    Inventors: Richard Graham, Peter Bakhit, Orest Olejnik
  • Compositions containing alpha-2-adrenergic agonist components
    Patent number: 9295641
    Abstract: Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
    Type: Grant
    Filed: September 11, 2014
    Date of Patent: March 29, 2016
    Assignee: ALLERGAN, INC.
    Inventors: Richard Graham, Peter Bakhit, Orest Olejnik
  • COMPOSITIONS CONTAINING ALPHA-2-ADRENERGIC AGONIST COMPONENTS
    Publication number: 20150005312
    Abstract: Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
    Type: Application
    Filed: September 11, 2014
    Publication date: January 1, 2015
    Inventors: Richard Graham, Peter Bakhit, Orest Olejnik
  • COMPOSITIONS AND METHODS COMPRISING PROSTAGLANDIN-RELATED COMPOUNDS AND TREFOIL FACTOR FAMILY PEPTIDES FOR THE TREATMENT OF GLAUCOMA WITH REDUCED HYPEREMIA
    Publication number: 20070270346
    Abstract: Compositions, methods, and pharmaceutical products related to prostaglandin-related compounds and trefoil factor family peptides are disclosed herein. Of particular interest are compositions and methods useful for the treatment of glaucoma with a reduced occurrence of hyperemia.
    Type: Application
    Filed: June 12, 2007
    Publication date: November 22, 2007
    Inventors: Peter Bakhit, Richard Graham, Orest Olejnik
  • COMPOSITIONS AND METHODS COMPRISING PROSTAGLANDIN-RELATED COMPOUNDS AND TREFOIL FACTOR FAMILY PEPTIDES FOR THE TREATMENT OF GLAUCOMA WITH REDUCED HYPEREMIA
    Publication number: 20070244051
    Abstract: Compositions, methods, and pharmaceutical products related to prostaglandin-related compounds and trefoil factor family peptides are disclosed herein. Of particular interest are compositions and methods useful for the treatment of glaucoma with a reduced occurrence of hyperemia.
    Type: Application
    Filed: June 12, 2007
    Publication date: October 18, 2007
    Inventors: PETER BAKHIT, Richard Graham, Orest Olejnik
  • PREDNISOLONE ACETATE COMPOSITIONS
    Publication number: 20070238789
    Abstract: Prednisolone acetate compositions, and methods, eye drops, and medicaments related thereto, are disclosed herein.
    Type: Application
    Filed: March 31, 2006
    Publication date: October 11, 2007
    Inventors: Chin-Ming Chang, James Chang, Peter Bakhit
  • Pharmaceutical compositions comprising alpha-2-adrenergics and trefoil factor family peptides
    Publication number: 20070042951
    Abstract: Disclosed herein are dosage forms comprising an alpha-2-adrenergic agonist and a trefoil factor family peptide. Related to these dosage forms are methods of treating glaucoma or reducing intraocular pressure and methods of treating gastrointestinal disorders.
    Type: Application
    Filed: August 26, 2004
    Publication date: February 22, 2007
    Applicant: ALLERGAN, INC.
    Inventors: Orest Olejnik, Peter Bakhit, Richard Graham
  • Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs
    Publication number: 20060241037
    Abstract: Disclosed are methods of preventing or treating a disease or adverse condition affecting the gastrointestinal tract of a mammal which comprise orally administering to a mammal a therapeutically effective amount of a prodrug of a proton pump inhibitor and an effective amount of a trefoil family factor peptide, mucoadhesive agent, or a combination thereof. Also disclosed are compositions which are suitable for use in a pharmaceutical dosage form. These compositions comprise a prodrug of a proton pump inhibitor, and also comprise a trefoil family factor peptide, a mucoadhesive component, or a combination thereof.
    Type: Application
    Filed: August 25, 2004
    Publication date: October 26, 2006
    Applicant: ALLERGAN INC.
    Inventors: Orest Olejnik, Peter Bakhit, Richard Graham, Jie Shen, Devin Welty, Diane Tang-Liu
  • Compositions and methods comprising prostaglandin related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
    Publication number: 20060046958
    Abstract: Compositions, methods, and pharmaceutical products related to prostaglandin-related compounds and trefoil factor family peptides are disclosed herein. Of particular interest are compositions and methods useful for the treatment of glaucoma with a reduced occurrence of hyperemia.
    Type: Application
    Filed: August 25, 2004
    Publication date: March 2, 2006
    Inventors: Peter Bakhit, Richard Graham, Orest Olejnik
  • Compositions containing alpha-2-adrenergic agonist components
    Publication number: 20050026924
    Abstract: Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
    Type: Application
    Filed: August 27, 2004
    Publication date: February 3, 2005
    Inventors: Richard Graham, Peter Bakhit, Orest Olejnik
  • Ophthalmic compositions comprising trefoil factor family peptides
    Publication number: 20050014691
    Abstract: This invention relates to compositions comprising trefoil family factor peptides which are useful in preventing or treating dry eye by topical administration of the composition to eye of the patient. One aspect of this invention relates to topical ophthalmic compositions comprising a trefoil factor family peptide, and preferably, a mucoadhesive component, as described herein. Another aspect of this invention relates to the use of these compositions to treat or prevent dry eye in a patient.
    Type: Application
    Filed: July 15, 2003
    Publication date: January 20, 2005
    Inventors: Peter Bakhit, Orest Olejnik, Richard Graham
  • Compositions containing alpha-2-adrenergic agonist components
    Publication number: 20040219219
    Abstract: Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
    Type: Application
    Filed: May 21, 2004
    Publication date: November 4, 2004
    Applicant: ALLERGAN, INC.
    Inventors: Richard Graham, Peter Bakhit, Orest Olejnik
  • Compositions containing alpha-2-adrenergic agonist components
    Publication number: 20040214829
    Abstract: Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
    Type: Application
    Filed: May 21, 2004
    Publication date: October 28, 2004
    Applicant: ALLERGAN, INC.
    Inventors: Richard Graham, Peter Bakhit, Orest Olejnik